bioAffinity Technologies, Inc.
Company Information
Industry
Services-Commercial Physical & Biological Research
SIC Code
8731
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
3300 NACOGDOCHES ROAD, SAN ANTONIO, TX, 78217
Mailing Address
3300 NACOGDOCHES ROAD, SAN ANTONIO, TX, 78217
Phone
210-698-5334
Fiscal Year End
1231
EIN
465211056
Financial Overview
FY2025
$7.28M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 16, 2026 | View on SEC |
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 13, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Initial commercial launch of CyPath® Lung, generating first revenue.
- Achieved a 150% revenue increase in 2025, signaling early commercial momentum.
Related Companies
Companies in the same industry (SIC: 8731)
iSpecimen Inc.
ISPC
Services-Commercial Physical & Biological Research
OneMedNet Corp
ONMD
Services-Commercial Physical & Biological Research
MAXCYTE, INC.
MXCT
Services-Commercial Physical & Biological Research
FOXO TECHNOLOGIES INC.
FOXO
Services-Commercial Physical & Biological Research
Absci Corp
ABSI
Services-Commercial Physical & Biological Research
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.